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Several DNA viruses and retroviruses are capa-
ble of integrating their genetic material into 
the host genome, which ensures viral genome 
maintenance and replication during cell divi-
sion (Li et al., 2006; Hall et al., 2008). Among 
the DNA viruses, members of the Herpesviridae, 
which infect animals as diverse as crustaceans 
and humans, are known to be capable of ge-
nomic  integration. Although  EBV  is  found 
integrated in only a small fraction of latently 
infected cells, human herpesvirus 6 (HHV-6) 
and Marek’s disease virus (MDV) are found ex-
clusively in an integrated state during the qui-
escent stage of the viral life cycle (Gulley et al., 
1992;  Delecluse  and  Hammerschmidt,  1993; 
Luppi  et  al.,  1993;  Hall  et  al.,  2008).  Other 
members of this group of viruses maintain their 
genomes  exclusively  in  an  episomal  state 
during this phase of infection (Mitchell et al., 
2003). Establishment of latency is a unifying 
and  important  principle  for  all  herpesviruses 
that  is  used  for  prolonged,  usually  life-long, 
maintenance  of  the  genetic  material  of  this 
group  of  pathogens  in  once-infected  hosts 
(Cohrs and Gilden, 2001). From the latent state, 
virus is reactivated intermittently to allow virus 
spread from infected to uninfected individuals 
in  a  population  (Jones,  1998).  Latency  is  a 
poorly understood series of events, which will 
uniformly result in the expression of only very 
few viral genes with the sole purpose of ge-
nome maintenance and the avoidance of a fully 
lytic replicative cycle resulting in cellular death 
(Cohrs and Gilden, 2001). Dependent on the 
cell populations targeted by individual herpes-
viruses, latency may only require genome main-
tenance  when  nonproliferative  cells  such  as 
neurons  are  infected.  However,  in  other  cell 
types,  for  example,  lymphocytes,  faithful  and 
continued replication of viral DNA during each 
mitosis must be ensured (Stevens, 1989; Cesarman 
and Mesri, 2007).
Although herpesvirus integration is a well 
known phenomenon, the mechanistic principles 
underlying  the  process  have  remained  entirely 
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Some herpesviruses, particularly lymphotropic viruses such as Marek’s disease virus (MDV) 
and human herpesvirus 6 (HHV-6), integrate their DNA into host chromosomes. MDV and 
HHV-6, among other herpesviruses, harbor telomeric repeats (TMRs) identical to host telo-
meres at either end of their linear genomes. Using MDV as a natural virus-host model, we 
show that herpesvirus TMRs facilitate viral genome integration into host telomeres and that 
integration is important for establishment of latency and lymphoma formation. Integration 
into host telomeres also aids in reactivation from the quiescent state of infection. Our 
results and the presence of TMRs in many herpesviruses suggest that integration mediated 
by viral TMRs is a conserved mechanism, which ensures faithful virus genome maintenance 
in host cells during cell division and allows efficient mobilization of dormant viral genomes. 
This finding is of particular importance as reactivation is critical for virus spread between 
susceptible individuals and is necessary for continued herpesvirus evolution and survival.
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the publication date (see http://www.rupress.org/terms). After six months it is 
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Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
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In the case of MDV, genomic integration 
and efficient induction of the latent state of 
infection is considered an important prelude 
to  transformation  and  tumor  formation, 
because the efficiency of lymphoma forma-
tion has been shown to correlate directly 
with the number of cells harboring latent 
genomes. Out of many latently infected and 
initially transformed cells, one out-competes 
all others with the consequence that tumors 
within  one  animal  are  almost  invariably 
monoclonal (Delecluse and Hammerschmidt, 
1993; Delecluse et al., 1993). During the 
latent state of MDV infection, few proteins 
and RNAs are produced, which ensure the 
establishment and maintenance of the quies-
cent  state  of  infection  and  the  continued 
survival of the host cell. Arguably the most 
important latency- and tumor-associated 
MDV protein is Meq, which serves as a 
repressor of lytic viral gene products, a pre-
requisite for latency. However, Meq is also a potent tran-
scriptional activator in a heterodimeric complex with the 
proto-oncoprotein c-jun and can interact with p53 as well as 
RB, thereby enhancing transformation and T cell prolifera-
tion (Liu and Kung, 2000; Lupiani et al., 2004; Brown et al., 
2006; Osterrieder et al., 2006). Another factor shown to be 
important for MDV-induced tumorigenesis is viral telomer-
ase RNA (vTR), a homologue of cellular telomerase RNA 
(TR). As part of the telomerase complex, vTR ensures in-
creased telomerase activity, at early stages of lymphomagene-
sis, but also promotes tumor formation independently of its 
presence in the telomerase complex (Kaufer et al., 2010b). 
The functions of Meq and vTR contribute to the rapid onset 
of lymphomas and death of infected animals within a few 
weeks  of  infection. These  properties  make  MDV  and  the 
elusive. Previously, HHV-6 and MDV, two lymphotropic 
viruses which can cause lymphoma, have been found inte-
grated and their genomes are present at the distal ends of host 
chromosomes during latent infection (Delecluse et al., 1993; 
Luppi et al., 1994; Arbuckle et al., 2010). A recent study sug-
gested that HHV-6 integrates at the proximal end of telo-
meres,  protein-associated  repeat  sequences  which  protect 
chromosomes from damage and extensive shortening during 
DNA replication, and that integration in telomeres facilitates 
vertical transmission of the virus’ genetic material (Arbuckle 
et al., 2010). In addition, HHV-6A and B, HHV-7, MDV, 
and numerous other herpesviruses harbor telomeric repeats 
(TMRs) identical to host telomere sequences (TTAGGG)n 
at either end of their linear genomes (Kishi et al., 1988; 
Secchiero et al., 1995).
Figure 1.  Identification of MDV integration 
sites. (A) Schematic representation of potential inte-
gration sites of the MDV genome within the host 
chromosome. Fragments resulting from digestion 
with BclI are depicted and expected fragment sizes 
are given. Terminal MDV genome fragments (red 
bars), telomeres, and BclI restriction sites are indi-
cated. (B) PFGE analysis of LCL using BclI. PFGE pat-
terns of three representative cell lines analyzed by 
Southern blotting, probing for the left MDV terminus 
(TRL), right MDV terminus (TRS), or telomere se-
quences (TMR), are shown. The 22.4- and 27.0-kbp 
fragments correspond to uncleaved termini and  
internal repeat fragments of the viral DNA. Arrows 
indicate colocalization of fragments that contain the 
TRS and high molecular mass telomere sequences. 
Results are representative of three independent ex-
periments giving identical results. The number of 
integration sites detected by FISH is given at the 
bottom of the blot images.JEM VOL. 208, March 14, 2011 
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a telomere-specific probe (TMR), which demon-
strated that fragments reactive with the short repeat 
region of the genome (TRS; Fig. S1 A) coincided 
with bands positive for telomeres (Fig. 1 B). These 
results suggested that MDV does indeed integrate 
into or in very close proximity to the telomeres.   
To further determine whether MDV integrates into 
telomeres or at telomere termini, we probed for sequences 
specific for the other terminal genome region, the terminal 
repeat long sequences (TRL; Fig. S1 A). Hybridization with 
TRL sequences resulted in very short reactive fragments, indi-
cating that MDV integrates into telomeres, which are located 
at either the extreme proximal (subtelomeric) or distal end 
(Fig. 1 B). Our results for lymphotropic MDV, therefore, are in 
agreement with a recent study showing that integration of a 
human lymphotropic herpesvirus, HHV-6, occurs at the in-
ternal end of the telomeres (Arbuckle et al., 2010).
Integrity of viral TMRs is dispensable  
for virus growth in vitro
MDV DNA replication results in the formation of four iso-
mers, where its two unique segments (unique-long, UL; and 
unique-short, US) can invert relative to the long or short in-
verted repeat sequences (TRL and TRS). MDV DNA harbors 
an additional copy of TMRs that ensures the presence of telo-
meres at all possible termini of the four DNA isomers (Fig. S1 A). 
We addressed the question of whether the viral TMRs medi-
ate integration and if integration is important for establish-
ment  of  latency  and  oncogenesis  of  MDV. Therefore,  we 
replaced the repeats present in pRB-1B, an infectious bacte-
rial artificial chromosome (BAC) clone of the highly onco-
genic RB-1B MDV strain, with either structurally similar 
repeats harboring only two nucleotide exchanges (pTE1) rela-
tive to the telomere sequences or with completely scrambled 
repeats (pTE2; Fig. 2). We targeted both the terminal and in-
ternal TMR regions that each contain multiple (m) and short (s) 
TMRs. The mTMRs have 27 copies of TMRs in the case 
of RB-1B but up to 100 copies in other MDV stains, and 
sTMRs constantly specify 6 copies (Fig. 2). In an additional 
mutant, we deleted both copies of the multiple TMR region 
(pmTMR) to define the role of the longer repeats (Fig. 2). 
Based on the pTE1, pTE2, and pmTMR mutants, we also 
engineered revertant infectious clones in which the original 
telomere  sequences  were  restored  in  both  loci  (pTE1rev, 
pTE2rev, and pmTMRrev). All infectious clones were con-
firmed by PCR, DNA sequencing of the targeted regions, 
and multiple restriction fragment length polymorphism analyses 
chicken  an  optimal  natural  virus-host  model  for  studying 
herpesvirus integration and the effects on tumorigenesis.
Based on the observations of the presence of TMRs in   
viral genomes and integration into or near host telomeres, we 
hypothesized that herpesviruses use their TMR sequences for 
integration, thereby ensuring faithful replication and mainte-
nance of the viral genome in rapidly dividing cells. Using the 
natural  MDV-chicken  model,  we  show  that  herpesvirus 
TMRs indeed facilitate directed integration into host telo-
meres, which is required for efficient tumor formation but 
also virus reactivation from latency. In the absence of the viral 
TMRs, herpesvirus integration is severely impaired, occurs in 
the form of concatemers, and is found at single sites within 
chromosomes. Our observation that integration occurs even 
in the absence of viral TMRs suggests that herpesvirus inte-
gration into the host genome is not a corollary of MDV rep-
lication but rather an important step in the establishment of 
latency, transformation, and tumorigenesis, as well as reactiva-
tion and spread to susceptible hosts.
RESULTS
MDV integrates into host telomeres
MDV is a highly oncogenic animal herpesvirus (Osterrieder 
et al., 2006), for which integration of viral DNA into the host 
genome was shown to be highly efficient and to target the 
distal end of multiple chromosomes (Delecluse et al., 1993). 
To elucidate whether MDV is indeed integrated into host 
telomeres in MDV-transformed cells, we performed pulsed 
field  gel  electrophoresis  (PFGE)  experiments.  DNA  from 
MDV-induced lymphoblastoid cell lines (LCLs) were digested 
with BclI, a restriction enzyme frequently cutting in both the 
host and viral genome but not in TMRs (Fig. 1 A). Southern 
blot analysis using probes specific for the terminal fragment of 
the TRS of the viral genome revealed that MDV is integrated 
into large fragments of up to 450 kbp that were indigestible 
with BclI. The sizes of the reactive fragments were found to 
correlate well with those reported for chicken telomeres, which 
range in size between 10 and 2,000 kbp (Fig. 1 B; Delany   
et al., 2003). The presence of telomere repeat sequences in 
fragments containing the viral genome was confirmed using 
Figure 2.  MDV TMR mutants. Schematic representation 
of the MDV genome with a focus on viral a-like sequences 
containing the mTMR and sTMR regions present in the MDV 
genome. Recombinant BAC constructs in which the TMRs 
(TTAGGG)n were replaced by TE1 (TAAGGC)n or TE2 (ACGACA)n, 
as well as a BAC construct in which the mTMR region was 
deleted, are shown.608 Herpesvirus telomeres direct integration and reactivation | Kaufer et al.
Absence of herpesvirus TMRs significantly reduces disease 
incidence and tumor development
To address the role of the herpesvirus TMRs in disease and 
tumor development in vivo, 1-d-old P2a chickens highly sus-
ceptibly to MDV infection (Cole, 1968) were experimentally 
infected  with  parental  vRB-1B,  mutant  vTE1,  vTE2,  or 
vTMR viruses, or the respective revertant viruses. After in-
fection, we monitored viral levels in peripheral blood as well 
as disease and tumor development. Viral loads in the blood 
were only mildly affected in animals infected with vTE1, vTE2, 
or  vmTMR  (Fig.  3, A–C),  indicating  that  herpesvirus 
TMRs do not play a prominent role in lytic virus replication 
in vivo, similar to the situation in cultured cells. In stark con-
trast, disease and tumor development were severely impaired 
to ensure the integrity of the genome and to exclude fortu-
itous mutations that might have occurred elsewhere in the 
genome through the genetic manipulations. Southern blot 
analysis confirmed that the mutant and restored telomeric re-
peats were as designed in the recombinant viral genomes 
(Fig. S1 B). Recombinant viruses were reconstituted from 
BAC  DNA  in  chicken  embryo  cells  (CECs),  and  growth 
properties  were  evaluated  using  multistep  growth  kinetics 
(unpublished data) and plaque size assays. The viruses derived 
from pTE1 (vTE1), pTE2 (vTE2), and pmTMR (vmTMR) 
showed growth properties that were virtually indistinguish-
able from those of parental or revertant viruses (Fig. S2, A–C), 
confirming that neither the exact TMR sequences nor the 
mTMR region is important for lytic replication in vitro.
Figure 3.  Mutation of herpesvirus TMRs mildly affects lytic replication but severely impairs disease and tumor development in vivo.  
(A–C) qPCR analysis of the viral ICP4 gene and host iNOS gene. Blood samples of animals infected with wild-type (vRB-1B), telomere mutant (TE1, TE2, and 
vmTMR), or revertant (TE1rev, TE2rev, and vmTMRrev) viruses were taken at 4, 7, 10, 14, 21, and 28 days after infection, and total DNA was extracted. 
Mean MDV genome copies per 1 × 106 cells of eight infected chickens per group are shown with standard deviations (error bars) determined in one inde-
pendent experiment for the indicated viruses. (D–F) Marek’s disease (MD) incidence in percentage of chickens infected by the intraabdominal route with 
wild-type (vRB-1B; D, n = 5; E, n = 19; F, n = 19), telomere mutant (TE1, n = 7; TE2, n = 17; vmTMR, n = 19), or revertant (TE1rev, n = 8; TE2rev, n = 20; 
vmTMRrev, n = 20) viruses was monitored during the indicated time period after infection. (G–I) Tumor incidence in P2a chickens infected with indi-
cated viruses. Results are shown as mean tumor incidences in two (G), three (H), or four (I) independent experiments with standard deviations (error bars). 
The mean tumor incidences in chickens infected with vTE1 and vmTMR were significantly decreased compared with those infected with vRB-1B, which 
is indicated by asterisks (G, P = 0.021; I, P = 1.98 × 106). Each group contained between 5 and 20 animals with a mean group size of n = 13.6. vRB-1B, 
TTAGGG; TE1, TTAGGG→TAAGGC; TE2, TTAGGG→ACGACA; vmTMR, mTMR deletion.JEM VOL. 208, March 14, 2011 
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(97.5%; P = 1.26 × 108) or revertant viruses (vRev; 98%; P = 
3.68 × 106; Fig. 4 G).
To determine whether mutation of the TMRs affected 
interindividual spread within a population, we housed chick-
ens infected by the intraabdominal route together with unin-
fected chickens. Although mutant viruses were fully able to 
spread to uninfected animals, as indicated by quantitative (q) 
PCR detection of viral DNA in chicken blood (not depicted), 
disease  incidence  in  animals  infected  with  vTE1  (11.1%), 
vTE2 (25.0%), or vmTMR (33.3%) was dramatically di-
minished  when  compared  with  parental  or  repair  viruses 
(80–100%; Fig. 4, A–C). Tumor development was also signifi-
cantly  decreased in  chickens  infected  with  vTE1  (25.5%), 
in the telomere mutant viruses. Only 57.1, 47.1, and 57.9% of 
chickens,  infected  with  vTE1,  vTE2,  or  vmTMR,  re-
spectively,  developed  clinical  disease,  whereas  95–100%  of 
animals infected with either parental or revertant viruses 
presented with clinical disease (Fig. 3, D–F). Tumor develop-
ment was also significantly decreased in animals infected with 
vTE1 (65.7%, P = 0.021), vTE2 (48.6%), and vmTMR 
(61.4%,  P  =  1.98  ×  106)  when  compared  with  parental 
vRB-1B or repair viruses (95–100%; Fig. 3, G–I). Collectively, 
the  mean  tumor  incidence  of  60%  observed  after  intra-
abdominal infection with either of the three telomere mutants 
viruses (vMut) in nine independent experiments was sig-
nificantly reduced when compared with parental vRB-1B 
Figure 4.  Disease and tumor development are severely impaired in the absence of the viral TMRs in animals infected via the natural route 
of infection. (A–C) Marek’s disease (MD) incidence in the percentage determined for in-contact animals housed with chickens infected with vRB-1B (n = 9), 
vTE1 (n = 10), or vTE1rev (n = 10; A), vTE2 (n = 8) or vTE2rev (n = 9; B), and vmTMR (n = 8) or vmTMRrev (n = 8; C). Chickens were monitored  
during the indicated time period and MD was recorded after necropsy and gross pathological examination. (D and E) Tumor incidence in percentage of 
contact animals housed with animals infected with wild-type (vRB-1B), telomere mutant (TE1, TE2, and vmTMR), or revertant (TE1rev, TE2rev, and 
vmTMRrev) viruses as indicated. Results are shown as mean tumor incidences of two (D and E) or three (F) independent experiments with standard  
deviations (error bars). The mean tumor incidences in chickens infected with vmTMR (F) were significantly decreased compared with incidences in  
animals infected with vRB-1B as indicated by the asterisk (P = 0.011). Each group contained between 2 and 10 animals with a mean group size of n = 6.7.  
(G–I) Mean tumor incidence in highly susceptible P2a chickens infected by either the intraabdominal (G) or the natural (H) route of infection or in more resis-
tant N2a chickens (I) with parental vRB-1B, vMut (vTE1, vTE2, or vmTMR), or vRev (vTE1rev, vTE2rev, or vmTMRrev) viruses. Results are shown as mean 
tumor incidences of nine (G), seven (H), or four (I) independent experiments with standard deviations (error bars). The mean group sizes were n = 13.6 (G), 
n = 6.7 (H), and n = 19.5 (I). A significant decrease of mean tumor incidence compared with vRB-1B (G, P = 1.26 × 108; H, P = 2.17 × 107) or vRev  
(G, P = 3.68 × 106; H, P = 7.72 × 105; I, P = 0.001) is indicated with an asterisk. vRB-1B, TTAGGG; TE1, TTAGGG→TAAGGC; TE2, TTAGGG→ACGACA; 
vmTMR, mTMR deletion.610 Herpesvirus telomeres direct integration and reactivation | Kaufer et al.
corresponding revertant viruses (42.9–63.1%; Fig. S3, A–C). 
Overall, the mean tumor incidence of 21% observed after in-
fection of N2a chickens with either of the telomere mutants 
viruses (vMut) in four independent experiments was signifi-
cantly reduced when compared with revertant viruses (vRev; 
54.75%; P = 0.001; Fig. 4 I).
Integration defects of viruses harboring mutant TMRs
In the next series of experiments, we addressed the question 
of whether the telomere mutant viruses were still able to in-
tegrate their viral DNA into the host genome and performed 
metaphase fluorescent in situ hybridization (FISH). Analysis 
of LCL derived from animals infected with parental vRB-1B, 
TMR mutants, or revertant viruses revealed that vTE1, vTE2, 
and vmTMR had severe integration defects. Although in-
tegration of wild-type MDV DNA was identified in the telo-
meres of up to 15 different chromosomes in individual LCL 
derived from chickens infected with vRB-1B or revertant 
viruses, vTE1, vTE2, and vmTMR DNA was found inte-
grated invariably in only one single chromosomal locus of 
each cell line (Fig. 5, A and B).
We then applied PFGE and Southern blot analyses to 
confirm whether integration of wild-type MDV DNA, as 
detected  by  FISH,  truly  represents  integration,  or  rather, 
tethering, of the viral episome to host chromosomes as was 
shown, for example, in the case of EBV (Sears et al., 2004). 
This approach also provided to us the opportunity to investi-
gate the status of viral DNA after integration of viruses with 
mutant TMRs.  Digestion  with  SfiI,  a  restriction  enzyme 
which does not cut within the MDV genome, allowed the 
distinction between integrated and nonintegrated/tethered 
MDV DNA (Fig. 6 A). Extended proteinase K digestion of 
LCL DNA embedded in agarose was applied to exclude the 
possibility of tethering of the viral genome to the host chro-
mosome by a proteinaceous structure. Consistent with the 
FISH results, multiple integration sites with varying sizes of 
reactive  fragments  were  identified  in  DNA  of  LCL  from   
animals infected with vRB-1B or vTE1rev. In contrast, in   
the case of LCL derived from vTE1-infected animals, inte-
gration was restricted to a single large DNA fragment of 
1.9 Mbp in size. To address whether the integration sites 
found in vTE1 LCL also mapped to telomeres, we per-
formed PFGE after BclI digestion. Southern blotting using 
either the TRS and TRL probe confirmed that vTE1 ge-
nomes were only detected in low molecular mass fragments 
of 4–20 kbp in size, with both the probes derived from ei-
ther terminal viral DNA fragment. We did not detect, how-
ever, any colocalization with telomere-containing fragments 
(Fig. 6 B; and Fig. S4, A–C). This data and identical results 
with LCL derived from vTE2-infected animals (unpublished 
data) demonstrated  that  only  minimal  changes  in  MDV 
TMR  sequences  abrogated  specific  integration  into  host 
telomeres and suggests that mutant viral DNA integrates into 
intrachromosomal  sites.  Intrachromosomal  integration  was 
detected  in  various  chromosomes  by  FISH  (unpublished 
data), suggesting that there is likely no preferred locus for 
vTE2 (25.0%), or vmTMR (27.8%; P = 0.01) when compared 
with  those  infected  with  parental  vRB-1B  or  repair  viruses 
(83.8–100%; Fig. 4, D–F). After infection by the aerosol route, 
mean tumor incidence was significantly reduced after infection 
with telomere mutant viruses (vMut; 26.3%) in seven indepen-
dent  experiments  when  compared  with  parental  vRB-1B 
(96.8%; P = 2.17 × 107) or revertant viruses (vRev; 86.6%; P = 
7.72 × 105; Fig. 4 H). The results suggested an even more drastic 
defect in tumor development of vTE1, vTE2, and vmTMR in 
chickens exposed by the natural route of infection.
To confirm that the defect in disease and tumor develop-
ment was not only restricted to chickens that are highly 
susceptible to MDV, we also infected N2a chickens, which 
exhibit increased resistance to MDV infection (Cole, 1968). 
Similar to the situation in P2a animals, tumor incidences 
were markedly reduced after infection of N2a chickens 
with vTE1 (25.6%), vTE2 (15.8%), or vmTMR (15.8%) 
when compared with the incidence after infection with the 
Figure 5.  Integration is severely impaired in the absence of the 
viral TMRs. (A) FISH analysis detecting MDV integration sites (anti-DIG 
FITC, green) in metaphase chromosomes (DAPI stain, blue) of representa-
tive cell lines of vRB-1B, vTE1, vTE2, and vmTMR. In the case of vTE1, 
vTE2, and vTMR, single integration sites are highlighted by arrows.  
(B) Mean number of integration sites in vRB-1B, mutant, and revertant 
cell lines. The number of analyzed cell lines and the frequencies of inte-
gration events are given. At least eight independent metaphase spread 
images were evaluated to determine the number of integration sites for 
each independent cell line.JEM VOL. 208, March 14, 2011 
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(Trapp et al., 2006; Kaufer et al., 2010b). 
vTR expression, as quantified by qRT-
PCR,  moderately  varied  between  cell 
lines (up to 3.3-fold) but levels were not 
dependent on whether wild-type, vTE1, 
or  revertant  cell  lines  were  analyzed   
(Fig. S5 A). Similarly,  Western blot analy-
sis confirmed that Meq expression was 
also variable between cell lines; how-
ever,  as  shown  for  vTR  transcription, 
there was no difference between vTE1 
cell lines when compared with wild-type and revertant cell 
lines (Fig. S5 B).
Reactivation of viruses with mutant  
TMRs is severely impaired
Finally, we determined whether integration of viral genomes 
into  telomeres  had  a  measurable  effect  on  virus  fitness,   
more specifically on reactivation of virus from the latent 
quiescent state of infection. Although genome maintenance 
during the latent phase of the virus life cycle is an important 
transitory phase, reactivation and spread to new hosts are   
essential for continued virus survival. Because integration 
into host telomeres could also provide an efficient mecha-
nism for virus genome mobilization through homologous 
recombination between virus and host telomeres, we ana-
lyzed the efficiency of virus reactivation from LCL. Reac-
tivation assays that rely on induction of the lytic replication 
cycle from latent genomes revealed that vTE1, vTE2, and 
vmTMR were severely impaired with respect to genome 
mobilization and their reactivation from latently infected 
cells (Fig. 7, A–C). The mean number of plaques per 1 × 106 
tumor cells induced on CECs was significantly (5–39-fold) 
decreased in the case of cell lines derived from chickens   
integration site or that nontelomeric integration sites are 
present in multiple chromosomes.
In  the  subsequent  experiments,  we  determined  if  the 
vTE1 mutant integrates as a single viral genome or as con-
catemers and analyzed MDV genome copy numbers in LCL. 
Large genome fragments with high intensities of reactive 
bands (Fig. 6 A) had already suggested that vTE1 DNA might 
be integrated not as a single copy but as multiples in the 
form  of  head-to-head  or  head-to-tail  concatemers. Viral 
copy numbers in LCL were determined by Southern blot 
analysis using normalization to copies of host 2 microglob-
ulin (B2M; Fig. S4, A-D). Although integrated at only one 
site, MDV genome copy numbers in all vTE1 cell lines ana-
lyzed were comparable to those present in CU482, a cell line 
with 11 integration sites, clearly indicating that vTE1 ge-
nomes were integrated as concatemers (Fig. 6 C and Fig. S4 E). 
In contrast, wild-type and revertant viruses can apparently 
also integrate as a single viral genome (Fig. 6 A). These find-
ings were also confirmed by qPCR analysis of numbers of 
viral DNA copies of individual LCLs (unpublished data).   
To address whether the site of integration has an effect on 
expression levels of known latency-associated genes, we ex-
amined vTR transcription and Meq protein levels in LCLs 
Figure 6.  Integration does not occur in host 
telomeres in the absence of viral TMRs.  
(A) Schematic representation and corresponding 
PFGE and Southern blot analysis of LCL DNA di-
gested with SfiI. Fragment sizes generated by SfiI 
digestion of integrated and nonintegrated MDV 
genomes are depicted and sizes are given. The 
size of the linear MDV genome observed during 
lytic replication is indicated by an arrow. Results 
are representative of three independent Southern 
blot analyses. (B) Southern blotting of DNA of LCL 
derived from animals infected with vTE1 and 
digested with BclI. Potential intragenomic and 
telomeric integration sites are indicated. Results 
are representative of three independent Southern 
blot analyses. (C) Quantification of MDV copies in 
tumor cells. Results are shown as mean herpesvi-
rus genome copies detected by the TRL probe 
relative to B2M in three independent experi-
ments. The data are shown relative to LCL CU482 
derived from a vRB-1B–infected chicken with 
standard deviations (error bars).612 Herpesvirus telomeres direct integration and reactivation | Kaufer et al.
It is well known that host telomere sequences prevent the 
induction of DNA damage responses (Blasco, 2005; Murnane, 
2006). We report in this paper that deletion or mutation of 
viral TMRs did not affect lytic replication in vitro and in vivo 
suggesting that viral telomeres do not seem to aid the evasion 
of DNA damage responses. However, we cannot exclude 
the tumor-promoting functions of MDV’s TMRs beyond 
facilitating integration into host telomeres. These potential 
functions will have to be the scope of future studies.
We can confirm in this paper that MDV integration is   
indeed, as previously shown for another herpesvirus, HHV-6, 
at telomere termini. PFGE analysis demonstrated that the in-
verted repeat short terminus of the genome, which contains 
the mTMR region in the linear MDV genome, is covalently 
linked to telomeres. Deletion of the mTMR region, which 
harbors a large but variable number of the hexameric repeats, 
confirmed that this region is involved in integration. Collec-
tively, we concluded that our data provide initial evidence 
that integration efficiency is directly correlated with tumor 
development and disease. It is conceivable that the integration 
event itself could influence disease development because epi-
genetic regulation of subtelomeric host genes could also have 
an effect on the expression of viral genes. It still remains un-
known, however, what exact role in the process of integration 
infected with vTE1 (1.13 × 104), vTE2 (7.06 × 104), and 
vmTMR (0.91 × 104) when compared with those from 
birds infected with parental vRB-1B (3.53 × 105; Fig. 7,   
A–C). We concluded that the presence of viral TMRs and 
the resulting integration of MDV DNA into host telomeres 
serves a purpose beyond genome maintenance during la-
tency by allowing efficient and rapid mobilization of virus 
genomes in response to external cues for initiation of the 
lytic phase of infection.
DISCUSSION
Herpesvirus integration into the host chromosome, as re-
ported for several lymphotropic herpesviruses, including 
EBV, HHV-6, and MDV, was viewed as an unintended conse-
quence and by-product of viral replication (Delecluse and 
Hammerschmidt, 1993; Luppi et al., 1993; Hall et al., 2008). 
In this paper, we provide the first evidence that telomere se-
quences present in the MDV genome and the genome of 
several other herpesvirus genomes facilitate directed integra-
tion  into  host  telomeres  (Delecluse  and  Hammerschmidt, 
1993; Arbuckle et al., 2010). We show that integration occurs 
very efficiently if TMRs in the virus genome are present. If, 
however, TMRs are absent or mutated, integration frequency 
is greatly reduced and occurs elsewhere intrachromosomally.
Figure 7.  Reactivation is significantly impaired in the absence of viral TMRs. (A–C) Reactivation assay using LCL derived from animals infected 
with wild-type (vRB-1B), telomere mutant (TE1, TE2, and vmTMR), or revertant (TE1rev, TE2rev, and vmTMRrev) viruses as indicated. Representative 
images of virus reactivation in CECs are shown. Bars, 500 µm. Quantification of reactivation assays is shown as the mean (horizontal bars) number of 
plaques per 1 × 106 tumor cells for each individual cell line (A–C, right), performed in triplicate for each of three independent experiments. Reactivation of 
lytic virus from vTE1-, vTE2-, and vmTMR-derived LCL was significantly reduced compared with that from vRB-1B–derived LCL, as indicated by the as-
terisks (A, P = 0.013; B, P = 0.039; C, P = 0.025). vRB-1B, TTAGGG; TE1, TTAGGG→TAAGGC; TE2, TTAGGG→ACGACA; vmTMR, mTMR deletion.JEM VOL. 208, March 14, 2011 
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mobilization of viral genomes from the integrated state was 
independent on the number of integration sites. Even in LCLs 
that presented with low copy numbers of latent viral DNA 
integrated into telomeres, mobilization and induction of lytic 
replication was significantly more efficient when compared 
with LCLs in which viral genomes did not harbor TMRs and, 
therefore, integrated elsewhere in the chromosome.
Finally, reduced reactivation levels likely cannot be at-
tributed to the loss of terminal sequences that could occur 
during a nontelomeric integration event. Mutant virus genomes 
were integrated in the form of concatemers as demonstrated 
in Fig. 6 (A–C). Integration in the form of concatemers could 
provide an explanation of how viral genomes are mobilized 
without the loss of sequence information, namely through HDR 
between repeat sequences of directly adjacent genomes.
In conclusion, we demonstrated that herpesvirus TMRs, 
which are present in several herpesviruses including HHV-6 
and MDV, facilitate directed integration into the host genome. 
Our results, therefore, provide the first conclusive evidence 
not only that herpesvirus TMRs mediate chromosomal integra-
tion but that these repeat structures are crucial for efficient 
tumor formation and reactivation of latent virus from the 
quiescent state of infection. Mutation or deletion of the TMRs 
resulted  in  decreased  integration  levels  with  only  a  single 
nontelomeric integration site within host chromosomes where 
viral genomes were present as concatemers. Our observation 
that integration occurs even in the absence of virus TMRs 
suggests that herpesvirus integration into the host genome is 
not simply a consequence of virus replication but, more likely, 
a prerequisite for transformation and tumorigenesis as well as 
for reactivation and spread to new susceptible hosts.
MATERIALS AND METHODS
Cells and viruses. CECs were prepared from specific pathogen-free em-
bryos and maintained as described previously (Osterrieder, 1999). Recombi-
nant viruses were reconstituted in CEC by CaPO4 transfection of purified 
BAC DNA as described previously (Schumacher et al., 2000; Jarosinski et al., 
2007b). The mini-F sequences flanked by loxP sites within the infectious clones 
were removed by cotransfection with a Cre recombinase expression vector 
(pCAGGS-NLS/Cre; Jarosinski et al., 2007b). Removal of mini-F sequences was 
ensured by analyzing recombinant virus stocks via PCR as described previously 
(Jarosinski et al., 2007b).  Virus propagation and determination of virus growth 
kinetics and plaque sizes were performed exactly as described previously 
(Schumacher et al., 2005). Viruses used for in vitro and in vivo experiments 
were passaged no more than five times in vitro. All virus stocks, as well as   
virus derived from tumor cells, were analyzed by DNA sequencing to ensure 
that no unexpected changes occurred in the loci targeted by mutagenesis.
Generation of mutant MDV . The MDV telomere region (Fig. 2) was am-
plified from pRB-1B and cloned into the pCR2.1 Topo vector (Invitrogen), 
resulting  in  pTMR.  Plasmids  containing  a  synthetic  telomere  region  in 
which viral TMRs (TTAGGG)n were replaced by telomere exchange repeats 
1 (TAAGGC)n or telomere exchange repeats 2 (ACGACA)n were obtained 
from Celtec and GenScript, respectively, and designated pTE1 and pTE2. 
Transfer plasmids for mutagenesis were generated as described previously 
(Tischer et al., 2006). In brief, the aphAI-I–SceI cassette was amplified from 
pEPkan-SII and inserted into pTMR, pTE1, or pTE2 using a unique SacI or 
NheI restriction site within the viral telomere region, resulting in the plas-
mids pTMR transfer, pTE1 transfer, and pTE2 transfer, respectively. Corre-
sponding transfer plasmids and oligonucleotides (Table S1) were used for 
is served by sTMR, which constantly specifies six copies of 
the TTAGGG repeats.
Efficient induction of the latent state of infection, likely 
initiated by efficient integration of the viral into the host ge-
nome, leads to lymphoma formation and therefore seems to 
play an important role in tumor formation in the model cho-
sen here. Integration into telomeres, as shown for MDV and 
HHV-6, could provide several advantages. The first advantage 
is the highly recombinogenic nature of TMRs, which could 
help facilitate efficient entry into the host genome. Homolo-
gous recombination between telomeres is known to ensure 
telomere maintenance via the so-called alternative telomere 
elongation (ALT) mechanism (Murnane, 2006). We presently 
surmise that ALT, or a very similar mechanism, is capable of 
mediating recombination between host and viral telomeres.   
It is notable that ALT is independent of the action of TR and 
TERT (telomerase reverse transcription), the two main com-
ponents of telomerase usually involved in the maintenance of 
protective telomere structures at the end of linear chromo-
somes (Murnane, 2006). ALT is commonly seen in telomer-
ase-deficient  cancer  cells  but  is  also  thought  to  occur  in 
certain somatic cell types (Perrem et al., 2001; Reddel, 2003). 
In addition, telomere recombination can be achieved by   
homology-directed repair (HDR) in the absence of an intact 
telomeric shelterin complex (Sfeir et al., 2010). We propose 
that the relatively short viral TMRs, consisting of only be-
tween 12 and 100 repeats (Spatz et al., 2007), will preclude 
assembly of the shelterin complex and the structure may, as 
such, be a potent inducer of HDR. It would be desirable to 
specifically interfere with HDR after infection of chickens 
with MDV to directly assess its role in integration and devel-
opment of latency; however, to our knowledge, HDR inhibi-
tors for in vivo use are currently not available.
The second advantage of telomere integration is the het-
erochromatic nature of telomeres and adjacent regions (Blasco, 
2005), which could aid in silencing of the viral genome dur-
ing the latent state of the viral life cycle. Our findings of 
higher frequencies of viral DNA integration and lymphomas 
in the presence of intact viral telomeres is fully consistent 
with these theoretical deliberations, as is the fact that muta-
tion of only two nucleotides in the TTAGGG repeat pre-
cludes efficient integration into host telomeres.
The third advantage, again dependent on the highly re-
combinogenic nature of the telomeres, could contribute to 
the efficient mobilization of the virus genome from the la-
tent, quiescent, and nonproductive state of infection. As 
observed for the frequency of integration, we determined 
significantly reduced reactivation levels if the virus does not 
harbor TMRs. Reduced reactivation was shown for two in-
dependent TMR mutant viruses and a virus in which the 
TMRs were deleted, manipulations which made integration 
into telomeres impossible. Mobilization of the virus genome 
is the first and most important step to be taken for the pro-
duction of fully replicating virus, which is absolutely required 
for interindividual spread and virus maintenance on a popu-
lation level. It is worthwhile pointing out that efficiency of 614 Herpesvirus telomeres direct integration and reactivation | Kaufer et al.
monoclonal mouse anti-Meq antibody (Brown et al., 2006; gift from V. Nair, 
Institute for Animal Health, Compton, England, UK), and -actin was probed 
with a monoclonal rabbit antibody (Cell Signaling Technology). The Meq 
antibody was used at dilution of 1:100, and the actin antibody was used at a 
1:1,000 dilution.
Reactivation assays. Established LCLs were purified via Histopaque 1119 
gradient centrifugation (Sigma-Aldrich; Parcells et al., 1999), washed with 
PBS, and serial 10-fold dilutions (103, 104, 105, or 106) of LCLs were seeded 
on fresh CEC cultures. MDV reactivation was stimulated by cocultivation of 
LCLs with CEC at low serum concentrations (0.1% FBS) and a tempera-
ture shift to 37°C as described previously (Calnek et al., 1981). LCLs were 
completely removed 24 h after seeding through extensive washing. 4 d after 
infection, CEC cultures were fixed, stained, and analyzed via immunofluores-
cence analysis using a chicken anti-MDV antiserum and visualized via an 
Alexa Fluor 488–conjugated anti–chicken antibody.
Statistical analysis. Significant differences in means of tumor incidences 
(Fig. 3, G–I; and Fig. 4, F–I) and LCL reactivation assays (Fig. 7, A–C) were 
determined using Student’s t test.
Online supplemental material. Fig. S1 depicts the four isomeric forms of 
the MDV genome and a Southern blot to confirm the mutation of TMRs in 
recombinant viruses. Fig. S2 presents plaque area determinations of telomere 
mutant viruses. Fig. S3 shows tumor incidences in N2a chickens infected 
with telomere mutant viruses. Fig. S4 gives a quantitative analysis of viral 
copy numbers in LCLs using Southern blot analysis. Fig. S5 shows vTR and 
Meq expression levels in LCLs derived from chicken infected with telomere 
mutant viruses. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20101402/DC1.
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